ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,01
0,54%
Dow Jones
38 225,66
0,00%
DAX
17 968,17
0,35%
Brent Oil
83,925
0,35%
Bitcoin
59 163,74
0,07%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Allakos Inc (ALLK)

  7. Allakos Inc (ALLK) Actualités

ALLK Allakos Inc

1,20
0,10 (9,09%)
Avant marché
Dernière mise à jour : 13:22:11
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Allakos Inc ALLK NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,10 9,09% 1,20 13:22:11
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,10
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
14/3/202421:02GLOBEAllakos Provides Business Update and Reports Fourth Quarter..
07/3/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:22EDGAR2Form 144 - Report of proposed sale of securities
04/3/202423:52EDGAR2Form 144 - Report of proposed sale of securities
26/2/202413:05EDGAR2Form 8-K - Current report
26/2/202413:02GLOBEAllakos Presents Preclinical Data Highlighting Inhibition of..
21/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202401:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/2/202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202413:07EDGAR2Form 8-K - Current report
12/2/202413:02GLOBEAllakos Announces Publication Highlighting AK006 Mast Cell..
02/2/202422:05EDGAR2Form 8-K - Current report
02/2/202418:31EDGAR2Form SC 13D/A - General statement of acquisition of..
16/1/202423:00EDGAR2Form 8-K - Current report
16/1/202413:02GLOBEAllakos Announces a Restructuring to Focus on Development of..
16/1/202413:00GLOBEAllakos Announces Phase 2 Lirentelimab Trials in Atopic..
05/1/202422:02EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202321:49EDGAR2Form 144 - Report of proposed sale of securities
04/12/202321:31EDGAR2Form 144 - Report of proposed sale of securities
04/12/202321:21EDGAR2Form 144 - Report of proposed sale of securities
27/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
13/11/202323:01EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:10EDGAR2Form 8-K - Current report
13/11/202322:02GLOBEAllakos Provides Business Update and Reports Third Quarter..
07/9/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202322:06EDGAR2Form 144 - Report of proposed sale of securities
05/9/202321:57EDGAR2Form 144 - Report of proposed sale of securities
05/9/202321:52EDGAR2Form 144 - Report of proposed sale of securities
30/8/202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:05EDGAR2Form 8-K - Current report
30/8/202322:05GLOBEAllakos Appoints Neil Graham to its Board of Directors
21/8/202322:02EDGAR2Form 8-K - Current report
09/8/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:08EDGAR2Form 8-K - Current report
09/8/202322:02GLOBEAllakos Provides Business Update and Reports Second Quarter..
04/8/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/8/202300:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202322:05GLOBEAllakos Appoints Rand Sutherland and Dolca Thomas to its..
02/8/202322:03EDGAR2Form 8-K - Current report
12/6/202313:02GLOBEAllakos Presents Preclinical Data at EAACI Hybrid Congress..

Dernières Valeurs Consultées

NASDAQ
ALLK
Allakos
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés